Heterocyclic compounds and uses as anticancer agents
US10799504B2 · kind B2 · utility
2Cited by
9References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2013 |
| Grant date | Oct 13, 2020 |
| Priority date | — |
| Expiry date | Jan 16, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment of tumors and related diseases related to the dysregulation of kinase (such as EGFR (including HER), Alk, PDGFR, but not limited to) pathways.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.